Cancer Clinical Trial
— VIVAOfficial title:
The Value of Integrating Visual Arts (VIVA): Evaluating the Benefits of Hospital Room Artwork on Inpatient Wellbeing
The Value of Integrating Visual Arts (VIVA): Evaluating the Benefits of Hospital Room Artwork on Inpatient Wellbeing will use a large randomized controlled trial design to investigate how the inclusion of visual arts in the hospital rooms of cancer patients benefits their quality-of-life during treatment. This 18-month research study will provide hospitals with evidence of the therapeutic value of the visual arts as measured by patients' perceptions of anxiety, pain ratings, use of pain medications, need for nurses, and length of stay. Data also will be collected on patients' evaluation of hospital rooms, specifically on décor including artwork, so as to correlate patient wellbeing with the presence of artwork. Ultimately, this project aims to increase support of and appreciation for the arts from a major consumer—namely, healthcare providers—by justifying the value of integrating local visual art into inpatient rooms and providing patients with aesthetic choice during their stay.
| Status | Completed |
| Enrollment | 184 |
| Est. completion date | August 2016 |
| Est. primary completion date | April 2016 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 18 Years to 90 Years |
| Eligibility |
Inclusion Criteria: - Patients who are admitted to the Penn State Hershey Cancer Institute (7th floor) for treatments including oncology, bone marrow transplant, and hematology. Patients will be 18 years or older Exclusion Criteria: - Patients whose treatments do not include oncology, bone marrow transplant, and hematology; who are not hospitalized on the 7th floor of the Cancer Institute; and who are not 18 years or older. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| United States | Penn State Hershey Medical Center | Hershey | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| Milton S. Hershey Medical Center |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Perceptions of anxiety as measured by the State-Trait Anxiety Inventory for Adults | Participants will be followed for the duration of hospital stay, an expected average of 2 weeks | No | |
| Secondary | Reports of pain as drawn for each patient via PowerChart, the hospital's electronic medical record software for documenting patient care | Participants will be followed for the duration of hospital stay, an expected average of 2 weeks | No | |
| Secondary | Use of pain medications as drawn for each patient via PowerChart, the hospital's electronic medical record software for documenting patient care | Participants will be followed for the duration of hospital stay, an expected average of 2 weeks | No | |
| Secondary | Mood as measured by the Mitchell Emotional Thermometer | Participants will be followed for the duration of hospital stay, an expected average of 2 weeks | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|